BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29077515)

  • 21. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma.
    Loukinov DI; Pugacheva E; Vatolin S; Pack SD; Moon H; Chernukhin I; Mannan P; Larsson E; Kanduri C; Vostrov AA; Cui H; Niemitz EL; Rasko JE; Docquier FM; Kistler M; Breen JJ; Zhuang Z; Quitschke WW; Renkawitz R; Klenova EM; Feinberg AP; Ohlsson R; Morse HC; Lobanenkov VV
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6806-11. PubMed ID: 12011441
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Hillman JC; Pugacheva EM; Barger CJ; Sribenja S; Rosario S; Albahrani M; Truskinovsky AM; Stablewski A; Liu S; Loukinov DI; Zentner GE; Lobanenkov VV; Karpf AR; Higgins MJ
    Mol Cancer Res; 2019 Oct; 17(10):2051-2062. PubMed ID: 31292201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the epigenetic factor BORIS (CTCFL) in the human genome.
    de Necochea-Campion R; Ghochikyan A; Josephs SF; Zacharias S; Woods E; Karimi-Busheri F; Alexandrescu DT; Chen CS; Agadjanyan MG; Carrier E
    J Transl Med; 2011 Dec; 9():213. PubMed ID: 22168535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
    Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE
    Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
    Zhao J; Wang Y; Liang Q; Xu Y; Sang J
    J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic Nature of CTCF Tandem 11 Zinc Fingers in Multivalent Recognition of DNA As Revealed by NMR Spectroscopy.
    Xu D; Ma R; Zhang J; Liu Z; Wu B; Peng J; Zhai Y; Gong Q; Shi Y; Wu J; Wu Q; Zhang Z; Ruan K
    J Phys Chem Lett; 2018 Jul; 9(14):4020-4028. PubMed ID: 29965776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTCF and BORIS in genome regulation and cancer.
    Marshall AD; Bailey CG; Rasko JE
    Curr Opin Genet Dev; 2014 Feb; 24():8-15. PubMed ID: 24657531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
    Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P
    PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CGGBP1 regulates CTCF occupancy at repeats.
    Patel D; Patel M; Datta S; Singh U
    Epigenetics Chromatin; 2019 Sep; 12(1):57. PubMed ID: 31547883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable Extent of Lineage-Specificity and Developmental Stage-Specificity of Cohesin and CCCTC-Binding Factor Binding Within the Immunoglobulin and T Cell Receptor Loci.
    Loguercio S; Barajas-Mora EM; Shih HY; Krangel MS; Feeney AJ
    Front Immunol; 2018; 9():425. PubMed ID: 29593713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.
    Link PA; Zhang W; Odunsi K; Karpf AR
    Cancer Immun; 2013; 13():6. PubMed ID: 23390377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes.
    VonHandorf A; Sánchez-Martín FJ; Biesiada J; Zhang H; Zhang X; Medvedovic M; Puga A
    Epigenetics; 2018; 13(4):363-375. PubMed ID: 29561703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTCF and CTCFL in cancer.
    Debaugny RE; Skok JA
    Curr Opin Genet Dev; 2020 Apr; 61():44-52. PubMed ID: 32334335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
    Fiorentino FP; Macaluso M; Miranda F; Montanari M; Russo A; Bagella L; Giordano A
    Mol Cancer Res; 2011 Feb; 9(2):225-33. PubMed ID: 21325284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CTCFL/BORIS for the immunotherapy of cancer.
    Loukinov D
    Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D-dependent chromatin association of CTCF in human monocytes.
    Neme A; Seuter S; Carlberg C
    Biochim Biophys Acta; 2016 Nov; 1859(11):1380-1388. PubMed ID: 27569350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early vertebrate origin of CTCFL, a CTCF paralog, revealed by proximity-guided shark genome scaffolding.
    Kadota M; Yamaguchi K; Hara Y; Kuraku S
    Sci Rep; 2020 Sep; 10(1):14629. PubMed ID: 32884037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 7C: Computational Chromosome Conformation Capture by Correlation of ChIP-seq at CTCF motifs.
    Ibn-Salem J; Andrade-Navarro MA
    BMC Genomics; 2019 Oct; 20(1):777. PubMed ID: 31653198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cell cycle role for the epigenetic factor CTCF-L/BORIS.
    Rosa-Garrido M; Ceballos L; Alonso-Lecue P; Abraira C; Delgado MD; Gandarillas A
    PLoS One; 2012; 7(6):e39371. PubMed ID: 22724006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells.
    Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS
    Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.